Accelerate Diagnostics investor relations material

Accelerate Diagnostics, Inc. (Accelerate), an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company's diagnostic platform utilizes its proprietary sandwich immunoassay technology to develop and commercialize assays that support the detection of clinically important viruses and bacteria associated with serious human diseases. Accelerate has developed a pipeline of diagnostic tests, including Carbapenemase (KPC) Nares Panel Kit; Meningitis Panel Kit; and Ebola Quick Test.